Polyneuropathy associated with neurofibromatosis;Neurofibromatoses et polyneuropathies

Revue Neurologique

Volumn 161, Issue 3, 2005, Pages 275-283

  Drouet, A ^a   Creange A ^b  

^a HIA Desgenettes   (France)

^b HENRI MONDOR HOSPITAL   (France)

Author keywords

Neurofibromatosis type 1; Neurofibromatosis type 2; Polyneuropathies; Schwannomatosis

Indexed keywords

DEMYELINATING NEUROPATHY; DISEASE ASSOCIATION; HUMAN; MORBIDITY; MORTALITY; NERVE FIBER DEGENERATION; NERVE SHEATH TUMOR; NEURILEMOMA; NEUROFIBROMATOSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; POLYNEUROPATHY; REVIEW; SENSORIMOTOR NEUROPATHY; SEX DIFFERENCE; SPINAL CORD COMPRESSION; SYMPTOMATOLOGY;

EID: 16844386703     PISSN: 00353787     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0035-3787(05)85033-7     Document Type: Review

References (56)

1. AïDI S, EL ALAOUI PARIS M, AMARTI A et al. (2002). Polyradiculoneuropathie inflammatoire démyélinisante chronique hypertrophique avec atteinte des nerfs crâniens: à propos de deux observations. Rev Neurol (Paris), 750: 819-823.
2. ANTINHEIMO J, SANKILA R, CARPEN O, PUKKALA E, SAINIO M, JAASKELAINEN J. (2000). Population-based analysis of sporadic and type 2 neurofibromatosis- associated meningiomas and schwannomas. Neurology, 54: 71-76.
3. AUSTIN JH. (1958). Recurrent polyneuropathies and their corticosteroid treatment. Brain, 81: 157-192.
4. BEQUET D, LABAUGE P, LARROQUE P, RENARD JL, GOASGUEN J. (1990). Neurofibromatose périphérique et atteinte des nerfs lombo-sacrés. Intérêt de l'imagerie médicale. Rev Neurol (Paris), 746: 757-761.
5. BIELSCHOWSKY M. (1923). Familiäre hypertrophische neuritis und neurofibromatose. J Psychol Neurol Lpz, 29: 247-280.
6. BERNARDS A. (1995). Neurofibromatosis type 1 and RAS-médiated signalling: filling in GAPs. Biochim Biophys Actua, 1242: 43-59.
7. BORDURE P, SAUVAGET E, STALDER JF, GAYET DELACROIX M, BEAUVILLAIN DE MONTREIL C. (1997). Hearing loss in neurofibromatosis type 1. Genet Couns, 358.
8. BOSCH EP, MURPHY MJ, CANCILLA PA. (1981). Peripheral neurofibromatosis and peroneal muscular atrophy. Neurology, 31: 1408-1414.
9. BRADLEY WG, RICHARDSON J, FREW IJC. (1974). The familial association of the neurofibromatosis, peroneal muscular atrophy, congenital deafness, partial albinism and Axenfeld's defect. Brain, 97: 521-532.
10. CANALE D, BEDIN J, KNIGHTON RS. (1964). Neurologic manifestations of von Recklinghausen's disease of the nervous system. Confin Neurol, 24: 359-403.
11. CREANGE A, ZELLER J, ROSTAING-RIGATTIERI S, BRUGIERE P, DEGOS JD, REVUZ J, WOLKENSTEIN P. (1999). Neurological complications of neurofibromatosis type 1 in adulthood. Brain, 122: 473-481.
12. DROUET A, WOLKENSTEIN P, LEFAUCHEUR JP et al. (2004). Neurofibromatosis 1 associated neuropathies: a reappraisal. Brain, 727: 1993-2009.
13. EGELHOFF JC, BATES DJ, Ross JS, ROTHNER AD, COHEN BH. (1991). Spinal MR findings in neurofibromatosis types 1 and 2. AJNR, 13: 1071-1077.
14. EVANS DG, HUSON SM, DONNAI D, NEARY W, BLAIR V, NEWTON V, HARRIS R. (1992a). A clinical study of the type 2 neurofibromatosis. Q J Med, 304: 603-618.
15. EVANS DGR, HUSON SM, DONNAI D et al. (1992b). A genetic study of the neurofibromatosis in the United Kingdom. I. Prevalence, mutation rate, fitness, and confirmation of maternal transmission effect on severity. J Med Genet, 29: 841-856.
16. FERNER RE, HONAVAR M, GULLAN RW. (1989). Spinal neurofibroma presenting as atlanto-axial subluxation in von Recklinghausen neurofibromatosis. Neurofibromatosis, 2: 43-46.
17. FERNER RE, UPADHAYAYA M, OSBORN M, HUGHES RAC. (1996). Neurofibromatous neuropathy. J Neurol, 243: S20-S21.
18. FRIEDMAN JM, BIRCH PH. (1997). Type neurofibromatosis: a descriptive analysis of the disorder in 1,728 patients. Am J Med Genet, 70: 138-143.
19. GRAZZI L, CHIAPPARINI L, PARATI EA, GIOMBINI S, D'AMICO D, LEONE M, BUSSONE G. (1998). Type II neurofibromatosis presenting as quadriceps atrophy, Ifal J Neurol Sci, 19: 94-96.
20. GUTMANN DH, AYLSWORTH A, GAREY JC et al. (1997). The diagnostic evaluation and multidisciplinary management of neurofibromatosis 1 and neurofibromatosis 2. JAMA, 278: 51-57.
21. GIJTENBECK JMM, GABREELS-FESTEN AAWM, LAMMENS M, ZWARTS MJ, VAN ENGELEN BGM. (2001). Mononeuropathy multiplex as the initial manifestation of neurofibromatosis type 2. Neurology, 56: 1766-1768.
22. HAGEL C, LINDENAU M, LAMSZUS K, LUWE L, STAVROU D, MAUTNER VF. (2002). Polyneuropathy in neurofibromatosis 2: clinical findings, molecular genetics and neuropathological alterations in sural nerve biopsy specimens. Acta Neuropathologica, 104: 179-187.
23. HUGHES RAC. (1994). Neurological complications of neurofibromatosis 1. In: HUSON SM and HUGHES RAC, editors. The neurofibromatoses: a pathogenetic and clinical overview. London: Chapmann and Hall, 204-232.
24. HUSON SM, HARPER PS, COMPSTON DA. (1988). Von Recklinghausen neurofibromatosis: A Clinical and population study in south east wales. Brain, 111: 1355-1381.
25. IWATA A, KUNIMOTO M, INOUE K. (1998). Schwann cell proliferation as the cause of peripheral neuropathy in neurofibromatosis-2. J Neurol Sci, 156: 201-204.
26. JACOBY LB, JONES D, DAVIS K, KRONN D, SHORT MP, GUSELLA J, MAC COLLIN M. (1997). Molecular analysis of the NF2 tumor-suppressor gene in schwannomatosis. Am J Hum Genet, 61: 1293-1302.
27. KILPATRICK TJ, HJORTH RJ, GONZALES MF. (1992). A case of neurofibromatosis 2 presenting with a mononeuritis multipex. J Neurol Neurosurg Psychiatry, 55: 391-393.
28. LAMBERS K, ORTIZ DE ZARATE JC. (1952). Zentrale und periphere Neurofibromatose unter besonderer Berücksichtigung ihrer Beziehungen zür hypertrophischen Neuritis. Dtsch Z Nervenheil, 169: 289-307.
29. LUPSKI JR, PENTAO L, WILLIAMS LL, PATEL PI. (1993). Stable inheritance of the CMT1A DNA duplication in two patients with CMT1 and NF1. Am J Med Genet, 45: 92-96.
30. MAC COLLIN M, WOODFIN W, KRONN D, SHORT MP. (1996). Schwannomatosis: a clinical and pathologic study. Neurology, 46: 1072-1079.
31. MAC COLLIN M, WILLETT C, HEINRIC B, JACOBY LB, ACIERNO JS, PERRY A, LOUIS DN. (2003). Familial schwannomatosis: exclusion of the NF2 locus as germline event. Neurology, 60: 1968-1974.
32. MARINEAU C, MEREL P, ROULEAU GA, THOMAS G. (1995). Le gène de la neurofibromatose de type 2. Médecine Sciences, 11: 35-42.
33. MASUDA N, HAYASHI H, TANABE H. (1992). Nerve root and sciatic trunck enlargement in Déjérine-Sottas disease: MRI appearances. Neuroradiology, 35: 36-37.
34. MURPHY MJ, BOSH EP, CANCILLA P. (1980). Neurofibromatosis and peroneal muscular atrophy. Neurology, 30: 404-405.
35. NATIONAL INSTITUTES OF HEALTH CONSENSUS DEVELOPEMENT CONFERENCE NEUROFIBROMATOSIS. (1998). Conference statement. Arch Neurol, 45: 575-578.
36. OHNISHI A, NADA O. (1972). Ultrastructure of the onion-bulb-like structure observed in the sural nerve in a case on von Recklinghausen's disease. Acta Neuropathol, 20: 258-263.
37. OVERWEG-PLANDSOEN WCG, BROUWER-MLADIN R, BIJLSMA EK. (1997). Neurofibroamtosis type 2 in an adolescent boy with a polyneuropathy and a mutation in the NF-2 gene. Genet Couns, 358-359.
38. PALMOWSKI A, REICHMANN H, TOYLA KV. (1991). Neurofibromatous neuropathy. Muscle Nerve, 5: 478-479.
39. PARRY DM, ELDRIDGE R, KAISER-KUPFER MI, BOUZAS EA, PIKUS A, PATRONAS N. (1994). Neurofibromatosis 2 (NF2): clinical characteristics of 63 affected individuals and clinical evidence for heterogeneity. Am J Med Genet, 52: 450-461.
40. PASCUAL-CASTROVIEJO I, PASCUAL-PASCUAL SI, VIANO J, MARTINEZ V. (2000). Generalized nerve sheath tumors in neurofibromatosis type 1 (NF1). A case report. Neuropediatrics, 31: 211-213.
41. POYHONEN M, LEISTI EL, KYTOLA S, LEISTI J. (1997). Hereditary spinal neurofibromatosis: a rare form of NF1? J Med Genet, 34: 184-187.
42. RICCARDI VM. (1991). Neurofibromatosis: past, present and future. N Engl J Med, 324: 1283-1285.
43. nd ed. Baltimore: Johns Hopkins University Press.
44. ROSEN SA, WANG H, UEMATSU S, CORNBLATH DR, HURKO O. (1989). Compression from hypertrophied proximal nerve roots in Charcot-Marie-Tooth disease (HMSN I). Neurology, 39 (suppl): 233.
45. Roos KL, PASCUZZI RM, DUNN DW. (1989). Neurofibromatosis, Charcot-Marie-Tooth disease, or both? Neurofibromatosis, 2: 238-243.
46. ROULEAU GA, MEREL P, LUTCHMAN M et al. (1993). Alteration in a new gene encoding a putative membrane-organizing protein causes neurofibromatosis type 2. Nature, 363: 515-521.
47. RUGGIERI M, INCORPORA G, TRINGALI C, PAVONE L. (1999) Neurological manifestations of neurofibromatosis type 1 (NF1) in childhood. Med Genetik, 11: 475.
48. SEPPALA MT, SAINIO MA, HALTIA MJJ, KINNUNEN JJ, SETALA KH, JAASKELAINEN JE. (1998). Multiple schwannomas: schwannomatosis or neurofibromatosis type 2? J Neurosurg, 89: 36-41.
49. SIBURN PA, NICHOLSON GA, TEH BT et al. (1998). Charcot-Marie-Tooth disease and Noonan syndrome with giant proximal nerve hypertrophy. Neurology, 50: 1067-1073.
50. SPERFELD AD, HEIN C, SCHRODER JM, LUDOLPH AC, HANEMANN CO. (2002). Occurrence and characterization of peripheral nerve involvement in neurofibromatosis type 2. Brain, 125: 996-1004.
51. THAKKAR SD, FEIGEN U, MAUTNER VF. (1999). Spinal tumours in neurofibromatosis type 1: an MRI study of frequency, multiplicity and variety. Neuroradiology, 41: 625-629.
52. THOMAS PK, EAMES RA. (1971). Neurofibromatous neuropathy. In: Serratrice G, Roux H eds. Actualités de pathologie neuromuscualaire: advances in neuromuscular diseases. Paris: Ricker, 612.
53. THOMAS PK, KING RHM, CHIANG TR, SCARAVILLI F, SHARMA AK, DOWNIE AW. (1990). Neurofibromatous neuropathy. Muscle Nerve, 73: 93-101.
54. TRIVEDI R, BYRNE J, HUSON SM, DONAGHY M. (2000). Focal amyotrophy in neurofibromatosis 2. J Neurol Neurosurg Psychiatry, 69: 257-261.
55. TROFATTER JA, MAC COLLIN MM, RUTTER JL et al. (1993). A novel moesin-, ezrin-, radixin-like gene is a candidate for the neurofibromatosis 2 tumor suppressor. Cell, 72: 791-800.
56. YAMAMOTO T, MARUYAMA S, MIZUNO K. (2001). Schwannomatosis of the sciatic nerve. Skeletal Radiol, 30: 109-113.